[Effect of anti-arrhythmia agents on the impulse conduction to the heart].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001283:Atrioventricular Node / Q000187:drug effects; D002036:Bundle of His / Q000187:drug effects; D002301:Cardiac Glycosides / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D004341:Drug Evaluation; D005934:Glucagon / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002301:Cardiac Glycosides; D004232:Diuretics; D005938:Glucocorticoids; D010672:Phenytoin; D005934:Glucagon; D007545:Isoproterenol; D011188:Potassium; D010646:Phentolamine
O vliianii protivoaritmicheskikh sredstv na provedenie impul'sa v serdtse